Search

everythinglearnresearchcommunity

for

Search:↓

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Dapagliflozin helps protect heart cells under stress by improving mitochondrial function and reducing cell damage.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

A new metformin-based treatment may effectively promote hair growth with fewer side effects.

Ursolic acid from Ochrosia elliptica leaves may help manage PCOS symptoms.

BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.

Latanoprost and minoxidil effectively control hair loss and increase hair count.

Ziziphus spina-christi leaf extract lowered blood sugar and protected organs in diabetic rats.

Low-dose oral minoxidil is effective and safe for treating hair loss in men and women.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Low-dose oral minoxidil is safe and effective for treating hair loss, with most side effects being mild and reversible.

Changes in SHBG levels don't predict diabetes risk reduction.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

The "Flavosterol" emulgel meets quality standards for treating hair loss.

Sublingual minoxidil safely promotes hair growth.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

β-Sitosterol may help prevent heart disease, cancer, and diabetes, but more human studies are needed.